Nuclear receptors CAR and PXR as cardiometabolic regulators

The constitutive androstane receptor (CAR) and pregnane X receptor (PXR) were initially described as xenobiotic sensors, but an increasing number of studies have linked their activity to other important physiological processes including glucose and lipid metabolism, implying an expanded role as meta...

Full description

Saved in:
Bibliographic Details
Main Authors: Janne Hukkanen, Jenni Küblbeck, Jukka Hakkola, Jaana Rysä
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661825003172
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849344859987509248
author Janne Hukkanen
Jenni Küblbeck
Jukka Hakkola
Jaana Rysä
author_facet Janne Hukkanen
Jenni Küblbeck
Jukka Hakkola
Jaana Rysä
author_sort Janne Hukkanen
collection DOAJ
description The constitutive androstane receptor (CAR) and pregnane X receptor (PXR) were initially described as xenobiotic sensors, but an increasing number of studies have linked their activity to other important physiological processes including glucose and lipid metabolism, implying an expanded role as metabolic sensors. CAR and PXR are nuclear receptors, which share similarities in expression, ligand-specificity, and mechanism of transcriptional regulation but they have their distinct features as well. Together, they regulate a wide array of target genes, whose functions range from elimination of xenobiotics to energy metabolism. Both CAR and PXR have large ligand binding pockets, and especially the PXR pocket is flexible for structurally different chemicals. Consequently, CAR and PXR could have a role in mediating the harmful metabolic effects of drugs and environmental chemicals. Current knowledge supports a role for PXR in the regulation of lipid and cholesterol metabolism. The actions seem to be mostly unfavorable, since the activation of PXR has been shown to promote hepatic lipogenesis and hyperlipidemia, increase plasma cholesterol and impair hepatic LDL uptake. PXR and PXR-regulated circulating 4β-hydroxycholesterol may also influence blood pressure regulation. CAR, in contrast, tends to exert beneficial effects on lipid and glucose homeostasis, since CAR activation has been shown to reduce serum triglyceride and cholesterol levels and have anti-atherogenic properties. Here we review current knowledge on CAR and PXR as regulators of cardiometabolic functions, including glucose and lipid homeostasis, blood pressure regulation and atherosclerosis.
format Article
id doaj-art-5bfc9c18f89440889d891ccba5d5a7f8
institution Kabale University
issn 1096-1186
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj-art-5bfc9c18f89440889d891ccba5d5a7f82025-08-20T03:42:34ZengElsevierPharmacological Research1096-11862025-09-0121910789210.1016/j.phrs.2025.107892Nuclear receptors CAR and PXR as cardiometabolic regulatorsJanne Hukkanen0Jenni Küblbeck1Jukka Hakkola2Jaana Rysä3Research Unit of Biomedicine and Internal Medicine, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio 70211, FinlandResearch Unit of Biomedicine and Internal Medicine, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, FinlandSchool of Pharmacy, University of Eastern Finland, P.O. Box 1627, Kuopio 70211, Finland; Corresponding author.The constitutive androstane receptor (CAR) and pregnane X receptor (PXR) were initially described as xenobiotic sensors, but an increasing number of studies have linked their activity to other important physiological processes including glucose and lipid metabolism, implying an expanded role as metabolic sensors. CAR and PXR are nuclear receptors, which share similarities in expression, ligand-specificity, and mechanism of transcriptional regulation but they have their distinct features as well. Together, they regulate a wide array of target genes, whose functions range from elimination of xenobiotics to energy metabolism. Both CAR and PXR have large ligand binding pockets, and especially the PXR pocket is flexible for structurally different chemicals. Consequently, CAR and PXR could have a role in mediating the harmful metabolic effects of drugs and environmental chemicals. Current knowledge supports a role for PXR in the regulation of lipid and cholesterol metabolism. The actions seem to be mostly unfavorable, since the activation of PXR has been shown to promote hepatic lipogenesis and hyperlipidemia, increase plasma cholesterol and impair hepatic LDL uptake. PXR and PXR-regulated circulating 4β-hydroxycholesterol may also influence blood pressure regulation. CAR, in contrast, tends to exert beneficial effects on lipid and glucose homeostasis, since CAR activation has been shown to reduce serum triglyceride and cholesterol levels and have anti-atherogenic properties. Here we review current knowledge on CAR and PXR as regulators of cardiometabolic functions, including glucose and lipid homeostasis, blood pressure regulation and atherosclerosis.http://www.sciencedirect.com/science/article/pii/S1043661825003172AtherosclerosisBlood pressureHypercholesterolemiaHypertensionMetabolismNuclear receptor
spellingShingle Janne Hukkanen
Jenni Küblbeck
Jukka Hakkola
Jaana Rysä
Nuclear receptors CAR and PXR as cardiometabolic regulators
Pharmacological Research
Atherosclerosis
Blood pressure
Hypercholesterolemia
Hypertension
Metabolism
Nuclear receptor
title Nuclear receptors CAR and PXR as cardiometabolic regulators
title_full Nuclear receptors CAR and PXR as cardiometabolic regulators
title_fullStr Nuclear receptors CAR and PXR as cardiometabolic regulators
title_full_unstemmed Nuclear receptors CAR and PXR as cardiometabolic regulators
title_short Nuclear receptors CAR and PXR as cardiometabolic regulators
title_sort nuclear receptors car and pxr as cardiometabolic regulators
topic Atherosclerosis
Blood pressure
Hypercholesterolemia
Hypertension
Metabolism
Nuclear receptor
url http://www.sciencedirect.com/science/article/pii/S1043661825003172
work_keys_str_mv AT jannehukkanen nuclearreceptorscarandpxrascardiometabolicregulators
AT jennikublbeck nuclearreceptorscarandpxrascardiometabolicregulators
AT jukkahakkola nuclearreceptorscarandpxrascardiometabolicregulators
AT jaanarysa nuclearreceptorscarandpxrascardiometabolicregulators